AVMA news
From Congress to the courtroom, AVMA advocates for veterinarians
The AVMA’s advocacy on behalf of its members covers practically every aspect of veterinary medicine and takes place in the federal government,…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
Animal health advocacy
The AVMA’s advocacy work provides critical support for the work veterinary teams do every day to protect, promote, and advance animal health. Learn…
AVMA news
FDA concludes first premarket consultation for meat cultured from animal cells
In a historic move, the Food and Drug Administration’s premarket consultation for meat cultured from animal cells brings Upside Foods’ chicken closer…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
AVMA news
Raw pet food diets, pet population management policies headed to HOD
The AVMA House of Delegates, during its regular winter session, being held January 5-6, 2024, in Chicago, will vote on six resolutions that would…
AVMA news
Eliminating in-person VCPR requirement for telemedicine, proposed midlevel position discussed at information forum
Two proposals for change in the veterinary profession—the idea of a midlevel position (MLP) that would overlap the roles of the veterinarian and…
AVMA news
HHS, senators request DEA reschedule marijuana
Legislators are seeking to remove marijuana from the Controlled Substances Act (CSA) after the U.S. Department of Health and Human Services (HHS)…